Nanocarriers in topical photodynamic therapy.

Nanocarriers nanotechnology nonmalignant skin diseases skin cancer topical photodynamic therapy

Journal

Expert opinion on drug delivery
ISSN: 1744-7593
Titre abrégé: Expert Opin Drug Deliv
Pays: England
ID NLM: 101228421

Informations de publication

Date de publication:
13 Feb 2024
Historique:
medline: 13 2 2024
pubmed: 13 2 2024
entrez: 13 2 2024
Statut: aheadofprint

Résumé

Photodynamic therapy (PDT) has gained significant attention due to its superiority over conventional treatments. In the context of skin cancers and nonmalignant skin diseases, topical application of photosensitizer formulations onto affected skin, followed by illumination, offers distinct advantages. Topical PDT simplifies therapy by providing easy access to the skin, increasing drug concentration within the target area, and confining residual photosensitivity to the treated skin. However, the effectiveness of topical PDT is often hindered by challenges such as limited skin penetration or photosensitizer instability. Additionally, the hypoxic tumor environment poses further limitations. Nanocarriers present a promising solution to address these challenges. The objective of this review is to comprehensively explore and highlight the role of various nanocarriers in advancing topical PDT for the treatment of skin diseases. The primary focus is to address the challenges associated with conventional topical PDT approaches and demonstrate how nanotechnology-based strategies can overcome these challenges, thereby improving the overall efficiency and efficacy of PDT. Nanotechnology has revolutionized the field of PDT, offering innovative tools to combat the unfavorable features of photosensitizers and hurdles in PDT. Nanocarriers enhance skin penetration and stability of photosensitizers, provide controlled drug release, reduce needed dose, increase production of reactive oxygen species, while reducing side effects, thereby improving PDT effectiveness.

Identifiants

pubmed: 38349540
doi: 10.1080/17425247.2024.2318460
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Nina Dragicevic (N)

Department of Pharmacy, Singidunum University, Belgrade, Serbia.

Jelena Predic-Atkinson (J)

Department of Pharmacy, Singidunum University, Belgrade, Serbia.

Bojan Nikolic (B)

Faculty of Health and Business studies, Singidunum University, Valjevo, Serbia.

Snezana B Pajovic (SB)

Institute of Nuclear sciences "Vinča", National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Sanja Ivkovic (S)

Institute of Nuclear sciences "Vinča", National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Miroslav Adzic (M)

Institute of Nuclear sciences "Vinča", National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Classifications MeSH